$5.19B Market Cap.
BBIO Market Cap. (MRY)
BBIO Shares Outstanding (MRY)
BBIO Assets (MRY)
Total Assets
$919.34M
Total Liabilities
$2.38B
Total Investments
$143.75M
BBIO Income (MRY)
Revenue
$221.90M
Net Income
-$535.76M
Operating Expense
$811.00M
BBIO Cash Flow (MRY)
CF Operations
-$520.73M
CF Investing
$60.78M
CF Financing
$748.46M
BBIO Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
BBIO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $919,338,000 (68.26%) | $546,380,000 (-12.30%) | $623,036,000 (-38.48%) | $1,012,792,000 (43.95%) |
Assets Current | $720,692,000 (50.90%) | $477,593,000 (-12.98%) | $548,853,000 (-38.25%) | $888,858,000 (38.27%) |
Assets Non-Current | $198,646,000 (188.78%) | $68,787,000 (-7.27%) | $74,183,000 (-40.14%) | $123,934,000 (103.96%) |
Goodwill & Intangible Assets | $23,926,000 (-9.09%) | $26,319,000 (-8.33%) | $28,712,000 (-36.10%) | $44,934,000 (0%) |
Shareholders Equity | -$1,467,904,000 (-8.39%) | -$1,354,257,000 (-7.94%) | -$1,254,617,000 (-44.14%) | -$870,414,000 (-1603.15%) |
Property Plant & Equipment Net | $12,778,000 (-35.60%) | $19,843,000 (-21.40%) | $25,247,000 (-45.08%) | $45,973,000 (24.81%) |
Cash & Equivalents | $681,227,000 (73.52%) | $392,588,000 (-5.31%) | $414,619,000 (5.25%) | $393,949,000 (10.63%) |
Accumulated Other Comprehensive Income | $8,000 (-74.19%) | $31,000 (109.45%) | -$328,000 (-148.48%) | -$132,000 (-168.75%) |
Deferred Revenue | $31,699,000 (420.00%) | $6,096,000 (-25.26%) | $8,156,000 (0%) | $0 (0%) |
Total Investments | $143,747,000 (143.85%) | $58,949,000 (-38.10%) | $95,233,000 (-78.50%) | $442,891,000 (76.44%) |
Investments Current | $0 (0%) | $58,949,000 (-38.10%) | $95,233,000 (-78.50%) | $442,891,000 (76.44%) |
Investments Non-Current | $143,747,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $4,722,000 (169.67%) | $1,751,000 (-89.75%) | $17,079,000 (-13.52%) | $19,749,000 (0%) |
Trade & Non-Trade Payables | $9,618,000 (-9.73%) | $10,655,000 (-7.81%) | $11,558,000 (-2.74%) | $11,884,000 (32.86%) |
Accumulated Retained Earnings (Deficit) | -$3,096,263,000 (-20.92%) | -$2,560,501,000 (-33.49%) | -$1,918,149,000 (-33.49%) | -$1,436,966,000 (-61.68%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $2,209,675,000 (27.00%) | $1,739,838,000 (0.94%) | $1,723,564,000 (-0.15%) | $1,726,171,000 (248.17%) |
Debt Current | $4,506,000 (9.16%) | $4,128,000 (12.33%) | $3,675,000 (-25.58%) | $4,938,000 (-6.00%) |
Debt Non-Current | $2,205,169,000 (27.05%) | $1,735,710,000 (0.92%) | $1,719,889,000 (-0.08%) | $1,721,233,000 (250.89%) |
Total Liabilities | $2,376,950,000 (25.84%) | $1,888,915,000 (1.12%) | $1,867,960,000 (-0.55%) | $1,878,371,000 (215.32%) |
Liabilities Current | $154,400,000 (7.34%) | $143,844,000 (18.46%) | $121,428,000 (-10.10%) | $135,069,000 (41.21%) |
Liabilities Non-Current | $2,222,550,000 (27.36%) | $1,745,071,000 (-0.08%) | $1,746,532,000 (0.19%) | $1,743,302,000 (248.62%) |
BBIO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $221,902,000 (2285.27%) | $9,303,000 (-88.02%) | $77,648,000 (11.38%) | $69,716,000 (745.14%) |
Cost of Revenue | $3,878,000 (58.54%) | $2,446,000 (-28.77%) | $3,434,000 (10.28%) | $3,114,000 (0%) |
Selling General & Administrative Expense | $288,931,000 (91.87%) | $150,590,000 (5.17%) | $143,189,000 (-25.50%) | $192,210,000 (31.94%) |
Research & Development Expense | $506,461,000 (11.14%) | $455,711,000 (14.08%) | $399,462,000 (-11.43%) | $451,024,000 (33.82%) |
Operating Expenses | $810,997,000 (32.04%) | $614,227,000 (4.74%) | $586,416,000 (-8.83%) | $643,234,000 (33.25%) |
Interest Expense | $99,290,000 (22.14%) | $81,289,000 (1.06%) | $80,438,000 (71.96%) | $46,778,000 (27.62%) |
Income Tax Expense | $1,153,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$543,347,000 (16.82%) | -$653,251,000 (-34.79%) | -$484,652,000 (17.36%) | -$586,454,000 (-16.02%) |
Net Income to Non-Controlling Interests | -$7,585,000 (24.52%) | -$10,049,000 (-189.68%) | -$3,469,000 (85.49%) | -$23,915,000 (57.87%) |
Net Income | -$535,762,000 (16.70%) | -$643,202,000 (-33.67%) | -$481,183,000 (14.46%) | -$562,539,000 (-25.36%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$535,762,000 (16.70%) | -$643,202,000 (-33.67%) | -$481,183,000 (14.46%) | -$562,539,000 (-25.36%) |
Weighted Average Shares | $186,075,873 (14.30%) | $162,791,511 (10.39%) | $147,473,076 (2.16%) | $144,356,619 (22.34%) |
Weighted Average Shares Diluted | $186,075,873 (14.30%) | $162,791,511 (10.39%) | $147,473,076 (2.16%) | $144,356,619 (22.34%) |
Earning Before Interest & Taxes (EBIT) | -$435,319,000 (22.53%) | -$561,913,000 (-40.22%) | -$400,745,000 (22.30%) | -$515,761,000 (-25.16%) |
Gross Profit | $218,024,000 (3079.58%) | $6,857,000 (-90.76%) | $74,214,000 (11.43%) | $66,602,000 (707.39%) |
Operating Income | -$592,973,000 (2.37%) | -$607,370,000 (-18.58%) | -$512,202,000 (11.17%) | -$576,632,000 (-21.53%) |
BBIO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $60,781,000 (12.49%) | $54,033,000 (-88.08%) | $453,147,000 (325.64%) | -$200,826,000 (-278.97%) |
Net Cash Flow from Financing | $748,457,000 (65.76%) | $451,535,000 (3537.91%) | -$13,134,000 (-101.78%) | $736,446,000 (64.68%) |
Net Cash Flow from Operations | -$520,726,000 (1.33%) | -$527,720,000 (-25.80%) | -$419,494,000 (15.75%) | -$497,934,000 (-24.57%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $288,512,000 (1402.42%) | -$22,152,000 (-207.96%) | $20,519,000 (-45.55%) | $37,686,000 (782.96%) |
Net Cash Flow - Business Acquisitions and Disposals | -$140,000 (72.17%) | -$503,000 (-105.03%) | $10,000,000 (-26.76%) | $13,654,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $69,829,000 (25.05%) | $55,842,000 (-83.55%) | $339,468,000 (304.21%) | -$166,234,000 (-329.38%) |
Capital Expenditure | -$933,000 (28.56%) | -$1,306,000 (-101.24%) | $105,179,000 (894.04%) | -$13,246,000 (-76.19%) |
Issuance (Repayment) of Debt Securities | $433,084,000 (0%) | $0 (0%) | -$20,486,000 (-101.93%) | $1,063,613,000 (98.08%) |
Issuance (Purchase) of Equity Shares | $311,717,000 (-30.16%) | $446,328,000 (7530.84%) | $5,849,000 (102.91%) | -$200,925,000 (-169.67%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $95,800,000 (-11.88%) | $108,710,000 (18.73%) | $91,559,000 (-7.99%) | $99,505,000 (70.21%) |
Depreciation Amortization & Accretion | $10,185,000 (-3.24%) | $10,526,000 (-11.86%) | $11,943,000 (4.27%) | $11,454,000 (152.07%) |
BBIO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 98.30% (33.38%) | 73.70% (-22.91%) | 95.60% (0.10%) | 95.50% (-4.50%) |
Profit Margin | -241.40% (96.51%) | -6913.90% (-1015.69%) | -619.70% (23.20%) | -806.90% (85.17%) |
EBITDA Margin | -191.60% (96.77%) | -5927.00% (-1083.74%) | -500.70% (30.79%) | -723.40% (85.36%) |
Return on Average Equity (ROAE) | 44.30% (-11.40%) | 50.00% (15.74%) | 43.20% (-52.53%) | 91.00% (144.00%) |
Return on Average Assets (ROAA) | -66.40% (39.86%) | -110.40% (-73.58%) | -63.60% (-12.17%) | -56.70% (-6.98%) |
Return on Sales (ROS) | -196.20% (96.75%) | -6040.10% (-1070.34%) | -516.10% (30.24%) | -739.80% (85.19%) |
Return on Invested Capital (ROIC) | -22.20% (30.63%) | -32.00% (-50.94%) | -21.20% (18.77%) | -26.10% (52.97%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -9.53 (6.77%) | -10.22 (-337.31%) | -2.34 (45.36%) | -4.28 (77.14%) |
Price to Sales Ratio (P/S) | 23.01 (-96.74%) | 706.43 (4781.34%) | 14.47 (-58.10%) | 34.54 (-96.60%) |
Price to Book Ratio (P/B) | -3.53 (31.87%) | -5.19 (-471.15%) | -0.91 (67.80%) | -2.82 (-101.87%) |
Debt to Equity Ratio (D/E) | -1.62 (-16.06%) | -1.4 (6.31%) | -1.49 (31.00%) | -2.16 (-120.98%) |
Earnings Per Share (EPS) | -2.88 (27.09%) | -3.95 (-21.17%) | -3.26 (16.41%) | -3.9 (-2.63%) |
Sales Per Share (SPS) | 1.19 (1992.98%) | 0.06 (-89.18%) | 0.53 (9.11%) | 0.48 (590.00%) |
Free Cash Flow Per Share (FCFPS) | -2.8 (13.75%) | -3.25 (-52.51%) | -2.13 (39.82%) | -3.54 (-2.61%) |
Book Value Per Share (BVPS) | -7.89 (5.17%) | -8.32 (2.21%) | -8.51 (-41.08%) | -6.03 (-1328.11%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.81 (50.61%) | 3.19 (-20.72%) | 4.03 (-39.90%) | 6.71 (12.44%) |
Enterprise Value Over EBIT (EV/EBIT) | -15 (0.00%) | -15 (-150.00%) | -6 (14.29%) | -7 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -15.31 (-2.52%) | -14.94 (-144.87%) | -6.1 (16.25%) | -7.28 (66.39%) |
Asset Turnover | 0.28 (1618.75%) | 0.02 (-84.47%) | 0.1 (47.14%) | 0.07 (600.00%) |
Current Ratio | 4.67 (40.60%) | 3.32 (-26.55%) | 4.52 (-31.32%) | 6.58 (-2.08%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$521,659,000 (1.39%) | -$529,026,000 (-68.31%) | -$314,315,000 (38.51%) | -$511,180,000 (-25.53%) |
Enterprise Value (EV) | $6,509,896,167 (-20.96%) | $8,236,214,889 (247.29%) | $2,371,563,481 (-35.44%) | $3,673,387,438 (-58.41%) |
Earnings Before Tax (EBT) | -$534,609,000 (16.88%) | -$643,202,000 (-33.67%) | -$481,183,000 (14.46%) | -$562,539,000 (-25.36%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$425,134,000 (22.90%) | -$551,387,000 (-41.82%) | -$388,802,000 (22.90%) | -$504,307,000 (-23.75%) |
Invested Capital | $2,269,460,000 (31.68%) | $1,723,467,000 (-3.28%) | $1,781,841,000 (-17.70%) | $2,165,011,000 (189.58%) |
Working Capital | $566,292,000 (69.68%) | $333,749,000 (-21.92%) | $427,425,000 (-43.30%) | $753,789,000 (37.76%) |
Tangible Asset Value | $895,412,000 (72.17%) | $520,061,000 (-12.50%) | $594,324,000 (-38.59%) | $967,858,000 (37.56%) |
Market Capitalization | $5,185,880,167 (-26.16%) | $7,023,049,889 (516.56%) | $1,139,061,481 (-53.60%) | $2,454,738,438 (-71.84%) |
Average Equity | -$1,210,069,750 (6.00%) | -$1,287,372,000 (-15.47%) | -$1,114,890,500 (-80.30%) | -$618,349,750 (-384.91%) |
Average Assets | $807,005,750 (38.50%) | $582,682,250 (-23.01%) | $756,789,500 (-23.73%) | $992,277,500 (17.21%) |
Invested Capital Average | $1,961,767,250 (11.58%) | $1,758,228,750 (-7.01%) | $1,890,744,500 (-4.27%) | $1,975,177,000 (166.22%) |
Shares | 188,989,802 (8.64%) | 173,967,052 (16.38%) | 149,483,134 (1.57%) | 147,166,573 (20.07%) |
